About Crestica
Crestica is a company based in Hyderabad (India) founded in 2018. It operates as a B2B and B2C. Crestica offers products and services including Ferrocres XT Tablets, CresBan-21 Tablets, Clara Cu 250, OG Care 200ml Liquid, and Protica - DF. Crestica operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, OvaScience and Rejoni, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Crestica Life Sciences Private Limited
- Date of Incorporation 22 May, 2019
- Jurisdiction Madurai, Tamil Nadu, India
-
Annual Revenue
$26.34 K (USD)0as on Mar 31, 2020
-
Net Profit
$14.4 (USD)0as on Mar 31, 2020
-
EBITDA
$122.09 (USD)0as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Crestica
Crestica offers a comprehensive portfolio of products and services, including Ferrocres XT Tablets, CresBan-21 Tablets, Clara Cu 250, OG Care 200ml Liquid, and Protica - DF.
Tablets for supporting antenatal health and nutritional needs
Contraceptive tablets for birth control and family planning
IUCD device for long-term contraception options
Liquid supplement for infertility treatment support
Supplement providing essential nutrients for general health
Antibiotic tablets for treating infections and related conditions
Funding Insights of Crestica
Detailed funding history for Crestica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Crestica
Investment portfolio details for Crestica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Crestica
Detailed financials for Crestica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crestica Comparisons
Peer comparison for Crestica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Crestica
Crestica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, OvaScience and Rejoni, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of new fertility treatments for women
|
|
| Locked | Locked | Locked |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| Locked | Locked | Locked |
Therapeutics for women's health and infertility are developed.
|
Detailed competitors of Crestica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crestica
Complete news archive for Crestica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Crestica
Crestica was founded in 2018.
Crestica is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Crestica is $26.34K as on Mar 31, 2020.
Crestica Lifesciences , Based In Madurai, Tamil Nadu, India, Develops And Markets Quality Pharmaceutical Products Including Antenatal Care, Contraceptives, Infertility Treatments, And Nutritional Supplements. The Company Focuses On Making Healthcare Accessible Through Effective Medicines At Affordable Prices, Serving The Medical Community And Consumers. With Offices In Multiple States, They Expand Their Presence Across India While Prioritizing Value And Efficacy In Their Offerings.
Crestica's top competitors include Sprout Pharmaceuticals, Granata Bio and Rejoni.
Crestica offers Ferrocres XT Tablets, CresBan-21 Tablets, Clara Cu 250, OG Care 200ml Liquid, and 2 more products and services.